Getting to the CORE of Cardiorespiratory Fitness

May 14, 2024 by

Location: Pinn Hall G1G2

Date: May 30, 2024 - May 30, 2024

Start Time: 3:00 pm

End Time: 4:00 pm

Event Link

Lisa Farr, M.Ed, R.C.E.P will start the seminar with an overview of the Exercise Physiology Core Lab and offered services. Two principal investigators who utilize the lab will describe their research:

  • Antonio Abbate, MD, PhD, the EPCL Medical Director, will discuss The Virginia ART4 (Virginia Anakinra Response Trial 4, HSR220072), which is a phase II clinical trial of Anakinra, recombinant interleukin-1 receptor antagonist, or placebo, to preserve, or improve, cardiorespiratory fitness (CRF) in patients with acute ST-segment elevation myocardial infarction.
  • Katie Love, MD, will discuss her trial, Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes (HSR210198). In this trial, she seeks to test the hypothesis that in humans with T1D, GLP-1RA and exercise training each enhance insulin-meditated skeletal muscle microvascular perfusion via attenuating endothelial oxidative stress and thereby improving endothelial function.

For more information about this event, please contact Lisa Farr.

Filed Under: Events